|
NSCLC trial
|
Primary lung tumour and involved regional lymph nodes
|
66 Gy in 24 fractions
|
N.A.
|
Cisplatin 6 mg/m2 1.5–2 h before radiation on every radiotherapy day#
|
|
Breast cancer trial
|
Whole breast and involved regional lymph node areas
|
46.69 Gy in 23 fractions
|
SIB of 14.49 Gy in 23 fractions to macroscopic tumour in breast; sequential boost of 10 Gy in 5 fractions to macroscopic lymph nodes (only if applicable)
|
N.A.
|
|
HNSCC trial
|
Primary tumour and regional metastatic lymph nodes; elective lymph node volumes based on site of primary tumour and stage
|
70 Gy in 35 fractions
|
Elective fields: 46 Gy in 23 fractions (sequential boost technique) or 54.25 Gy in 35 fractions (SIB technique)
|
N.A.
|
